The clinical dosage range spans 2.510 mg per subcutaneous injection, titrated over 4 weeks before reaching a maintenance dose of 510 mg, five times weekly
In the United States, penta deca peptide arginate is available through licensed healthcare providers and compounding pharmacies, unlike BPC-157 acetate which the FDA classified as a Category 2 substance
The ideal approach depends on individual circumstances
The individual studies, published in Cephalgia in 2010, and the pooled results, published in Headache in 2010, both showed a significant decrease in the number of headache days (per 28 days) with eight to nine fewer headache days at 24 weeks as well as a significant improvement in quality of life in the Botox group
In many aesthetic settings, these lipotropic injections are integrated into larger medical weight loss programs
Its full scientific designation is Body Protection Compound-157, and it has been the subject of over 100 peer-reviewed studies, primarily in animal models, with growing human clinical application